MIF and neoplasm: myeloid-derived suppressor cells (MDSCs), an obstacle to cancer immunotherapies, accumulate in cancer and promotes tumor progression.30 Since MDSC accumulation in tumor is dependent on MIF,31 MDSC subsets in tumor after rSmeg-hMIF-hIL-7 administration were assessed by flow cytometry.